Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

484.41 -1.12 (-0.23%)
Streaming Delayed Price Updated: 2:22 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 476,731
Open 484.45
Bid (Size) 484.27 (1)
Ask (Size) 484.48 (2)
Prev. Close 485.53
Today's Range 480.10 - 486.43
52wk Range 335.82 - 485.85
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
From Vertex Pharmaceuticals Incorporated
Via Business Wire
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+17.89%
+17.89%
1 Month
+18.08%
+18.08%
3 Month
+17.99%
+17.99%
6 Month
+36.86%
+36.86%
1 Year
+38.74%
+38.74%

More News

Read More
Large Cap BIopharmaceuticals Overview
Via Talk Markets
Topics Stocks
Exposures US Equities
This Is What Whales Are Betting On Vertex Pharmaceuticals
Via Benzinga
3 No-Brainer Stocks to Buy in June
Via The Motley Fool
Analyst Expectations For Vertex Pharmaceuticals's Future
Via Benzinga
While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.
Via Chartmill
2 Biotech Stocks to Buy in May
Via The Motley Fool
5 Top Stocks to Buy in June
Via The Motley Fool
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
A Very Bullish Reversal Produces A Huge Batch Of Actionable Stocks
Via Talk Markets
Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists
Via Investor's Business Daily
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Via The Motley Fool
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Via Benzinga
Should you consider NASDAQ:VRTX for quality investing?
Via Chartmill
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Via Benzinga
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
Via Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
Via The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Via The Motley Fool
3 High-Flying Stocks That Could Soar Even More
Via The Motley Fool
SLB, First Solar And 2 Other Stocks Insiders Are Selling
Via Benzinga
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
Via Benzinga
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
Via InvestorPlace
Vertex to Participate in Upcoming June Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.